タンパク質発現の世界市場規模・シェア・開発・成長・需要予測(2013~2023年):システム別(原核生物、哺乳類細胞、昆虫細胞、イースト、無細胞、藻類由来)・商品とサービス別(試薬、発現ベクター、適格細胞、サービス、機器)・用途別(治療用、工業用、研究用)・エンドユーザー別(医薬品・バイオテクノロジー企業、学術研究機関、CRO)・地域別(米国、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、中国、インド、日本、ブラジル、メキシコ、南アフリカ)

P&S Market Researchが発行した調査報告書(PSM802142)
◆英語タイトル:Protein Expression Market by System (Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, Algal-Based Expression Systems), by Product & Services (Reagents, Expression Vectors, Competent Cells, Services, Instruments), by Application (Therapeutic, Industrial, Research), by End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), by Geography (US, Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023
◆商品コード:PSM802142
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2017年10月1日
◆ページ数:231
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,500 ⇒換算¥605,000見積依頼/購入/質問フォーム
Group License(5名様閲覧用)USD6,100 ⇒換算¥671,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,100 ⇒換算¥1,001,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はP&S Market Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。P&S Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

According to the study, the global protein expression market is likely to grow from $1.4 billion in 2016 to $3.0 billion by 2023. Major key players in the market are developing products with technically advanced features that are designed to produce high protein yield, maintaining a balance of speed and scalability, thereby enhancing its application in the drug development workflow.
Some of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by ThermFisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling upto 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products are a major factor driving the growth of the market during the forecast period.

Insights on market segments

As per the findings of the research, prokaryotic expression system occupied the largest share of the protein expression market in 2016, due to the high use of prokaryotic protein expression systems, since they are cheaper as compared to other expression systems.

Based on products and services, reagents are expected to hold the largest share of the protein expression market during the forecast period, mainly attributable to increasing protein expression research activities and the large-scale production of antibodies and vaccines.

Based on application, therapeutics held the largest share of the market in 2016, owing to the increasing prevalence of chronic diseases such as cancer and diabetes around the world, and high efficacy of protein therapeutics.

Pharmaceutical & biotechnology companies were the largest end user of the protein expression products in 2016, mainly due to the technological advancement in protein expression research and rising production of recombinant therapeutic proteins for disease treatment.

North America stands as the largest protein expression market

Geographically, North America has been the largest market for protein expression, with the U.S. being the larger contributor to the regional market, as compared to Canada. The dominant position of the North American market is mainly attributable to the rise in R&D infrastructure, increased aging population, rise in healthcare expenditure and increasing prevalence of chronic diseases in the region.

Europe is the second largest market for protein expression, after North America. The Germany has been the largest contributor to the European protein expression market, followed by the U.K. and France. The growth of the European market is mainly attributable to the growing aging population, increase in infections, rising incidences of cardiovascular diseases, chronic pain, and neurological disorders and R&D infrastructure. The protein expression market is expected to witness the fastest growth in Asia-Pacific during forecast period. Rising prevalence of diseases such as cardiovascular disease and diabetes, increasing R&D spending, growing aging population and increasing per capita income are some of the driving factors boosting the Asia-Pacific market.

Mergers and acquisitions: a key trend in the market

Increasing number of acquisitions is a key trend observed in the protein expression market. The key players globally are acquiring segments and/or companies to increase their share in the global market. In January 2017, Bio-Rad Laboratories, Inc. (Bio-Rad) acquired RainDance Technologies, Inc. (RainDance). As per the terms of acquisition, RainDance Technologies, Inc. offered its droplet-based solutions to Bio-Rad Laboratories, Inc. and has extended its reach into next generation sequencing applications. Similarly, Takara Bio USA Holdings, Inc. (“TBUSH”) acquired Rubicon Genomics, Inc. (Rubicon) in January 2017, the acquisition was aimed at expanding the product portfolio in next generation sequencing sample preparation. TBUSH also completed its acquisition of WaferGen Bio-systems, Inc. (WaferGen) in March 2017.

Key players in the market are launching new products to offer advanced protein expression products

Key players are launching new products in the market to offer advanced protein expression products. In August 2017, Thermo Fisher Scientific Inc. launched Thermo Scientific Krios G3i which is designed to deliver innovative enhancements necessary for rapid adoption of cryo-EM. The Thermo Scientific Krios G3i can be used independently or together in a single particle analysis workflow to make structural analysis of the proteins, protein complexes and other biomolecular structures faster, easier and more accessible.

In July 2017, Agilent Technologies Inc. expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. Real-time polymerase chain reaction (PCR) is routinely used in laboratories to help identify pathogens, genotype infectious agents, and for cancer diagnostics. The open platform of AriaDx makes it compatible to existing fast chemistry-based assays that are DNA binding and probe-based. This feature enables assay developers and partners with optimized reaction chemistries to quickly validate their assays on the AriaDx.

Some of the other key players operating in this industry include Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., New England Biolabs Inc., and Lonza Group Ltd.

【レポートの目次】

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by System

1.3.2 Market Segmentation by Product & Services

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by End User

1.3.5 Market Segmentation by Geography

1.3.6 Analysis Period

1.3.7 Market Data Reporting Unit

1.3.7.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Data Triangulation

2.4 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By System

4.1.1.1 Prokaryotic expression systems

4.1.1.1.1 Escherichia coli systems

4.1.1.1.2 Other prokaryotic expression system

4.1.1.2 Mammalian cell expression systems

4.1.1.2.1 Chinese hamster ovary(CHO) systems

4.1.1.2.2 Other mammalian cell systems

4.1.1.3 Insect cell expression systems

4.1.1.3.1 Baculovirus systems

4.1.1.3.2 Other insect cell systems

4.1.1.4 Yeast expression systems

4.1.1.4.1 K. Lactis systems

4.1.1.4.2 Saccharomyces systems

4.1.1.4.3 Pichia systems

4.1.1.4.4 Other yeast expression systems

4.1.1.5 Cell-free expression systems

4.1.1.6 Algal-based expression systems

4.1.2 By Products & Services

4.1.2.1 Reagents

4.1.2.2 Expression vectors

4.1.2.3 Competent cells

4.1.2.4 Instruments

4.1.2.5 Services

4.1.3 By Application

4.1.3.1 Therapeutic

4.1.3.2 Industrial

4.1.3.3 Research

4.1.4 By End User

4.1.4.1 Pharmaceutical and biotechnology companies

4.1.4.2 Academic research institutes

4.1.4.3 Contract research organizations

4.1.4.4 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing number of acquisitions

4.2.1.2 Increasing research activities on recombinant-based protein expression

4.2.2 Drivers

4.2.2.1 Increasing prevalence of chronic diseases

4.2.2.2 Aging population

4.2.2.3 Increasing growth in life science sector

4.2.2.4 Availability of funding for protein-based research

4.2.2.5 Technological advancements

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Increasing market consolidation affecting new entrants

4.2.3.2 High cost of protein expression reagents and instruments

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Untapped market in various emerging economies

4.2.4.2 Emergence of microfluidics

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining power of buyers

4.3.2 Bargaining power of suppliers

4.3.3 Threat of new entrants

4.3.4 Intensity of rivalry

4.3.5 Threat of substitutes

Chapter 5. Global Market Size and Forecast

5.1 Global Protein Expression Market, by System

5.1.1 Global Prokaryotic Expression Systems Market, by Type

5.1.2 Global Mammalian Cell Expression Systems Market, by Type

5.1.3 Global Insect Cell Expression Systems Market, by Type

5.1.4 Global Yeast Expression Systems Market, By Type

5.2 Global Protein Expression Market, by Product & Services

5.3 Global Protein Expression Market, by Application

5.4 Global Protein Expression Market, by End User

5.5 Global Protein Expression Market, by Region

Chapter 6. North America Market Size and Forecast

6.1 North America Protein Expression Market, by System

6.1.1 North America Prokaryotic Expression System Market, by Type

6.1.2 North America Mammalian Cell Expression Systems Market, by Type

6.1.3 North America Insect Cell Expression Systems Market, by Type

6.1.4 North America Yeast Expression Systems Market, by Type

6.2 North America Protein Expression Market, by Product & Services

6.3 North America Protein Expression Market, by Application

6.4 North America Protein Expression Market, by End User

6.5 North America Protein Expression Market, by Country

Chapter 7. Europe Market Size and Forecast

7.1 Europe Protein Expression Market, by System

7.1.1 Europe Prokaryotic Expression System Market, by Type

7.1.2 Europe Mammalian Cell Expression Systems Market, by Type

7.1.3 Europe Insect Cell Expression Systems Market, by Type

7.1.4 Europe Yeast Expression Systems Market, by Type

7.2 Europe Protein Expression Market, by Product & Services

7.3 Europe Protein Expression Market, by Application

7.4 Europe Protein Expression Market, by End User

7.5 Europe Protein Expression Market, by Country

Chapter 8. Asia- Pacific Market Size and Forecast

8.1 Asia-Pacific Protein Expression Market, by System

8.1.1 Asia-Pacific Prokaryotic Expression System Market, by Type

8.1.2 Asia-Pacific Mammalian Cell Expression Systems Market, by Type

8.1.3 Asia-Pacific Insect Cell Expression Systems Market, by Type

8.1.4 Asia-Pacific Yeast Expression Systems Market, by Type

8.2 Asia-Pacific Protein Expression Market, by Product & Services

8.3 Asia-Pacific Protein Expression Market, by Application

8.4 Asia-Pacific Protein Expression Market, by End User

8.5 Asia-Pacific Protein Expression Market, by Country

Chapter 9. Latin America Market Size and Forecast

9.1 Latin America Protein Expression Market, by System

9.1.1 Latin America Prokaryotic Expression System Market, by Type

9.1.2 Latin America Mammalian Cell Expression Systems Market, by Type

9.1.3 Latin America Insect Cell Expression Systems Market, by Type

9.1.4 Latin America Yeast Expression Systems Market, by Type

9.2 Latin America Protein Expression Market by Product & Services

9.3 Latin America Protein Expression Market, by Application

9.4 Latin America Protein Expression Market, by End User

9.5 Latin America Protein Expression Market, by Country

Chapter 10. Middle East and Africa Market Size and Forecast

10.1 MEA Protein Expression Market, by System

10.1.1 Mea Prokaryotic Expression System Market, by Type

10.1.2 Mea Mammalian Cell Expression Systems Market, by Type

10.1.3 Mea Insect Cell Expression Systems Market, by Type

10.1.4 Mea Yeast Expression Systems Market, by Type

10.2 MEA Protein Expression Market, by Product & Services

10.3 MEA Protein Expression Market, by Application

10.4 MEA Protein Expression Market, by End User

10.5 MEA Protein Expression Market, by Country

Chapter 11. Global Mammalian Cell Expression System Market

11.1 Market Size for Recombinant Protein Production

11.1.1 Global Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.2 North America Mammalian Cell Expression Systems Market for Recombinant Protein Production, By Application

11.1.3 Europe Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.4 Asia-Pacific Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.5 Latin America Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.1.6 MEA Mammalian Cell Expression Systems Market for Recombinant Protein Production, by Application

11.2 Market Size for Recombinant Antibody Production

11.2.1 Global Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.2 North America Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.3 Europe Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.4 Asia-Pacific Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.5 Latin America Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.2.6 MEA Mammalian Cell Expression Systems Market for Recombinant Antibody Production, by Application

11.3 Market Share Analysis for Recombinant Antibody Production

11.4 Recombinant Antibody Production – Key Players

11.4.1 Abnova Corporation

11.4.2 General Electric Company

11.4.3 Sino Biological Inc.

11.4.4 Bioventix plc

Chapter 12. Competitive Landscape

12.1 Market Share Analysis of Key Players

12.2 Competitive Analysis of Key Players

12.3 Product Benchmarking of Key Players

12.4 Global Strategic Developments of Key Players

12.4.1 Merger and Acquisition

12.4.2 Product Launch/Approvals

12.4.3 Partnership

12.4.4 Other Developments

Chapter 13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Business Overview

13.1.2 Product and Service Offerings

13.1.3 Key Financial Summary

13.1.4 Strategic Growth Plans

13.2 Merck KGaA

13.2.1 Business Overview

13.2.2 Product and Service Offerings

13.2.3 Key Financial Summary

13.2.4 Strategic Growth Plans

13.3 Genscript Biotech Corporation

13.3.1 Business Overview

13.3.2 Product and Service Offerings

13.3.3 Key Financial Summary

13.3.4 Strategic Growth Plans

13.4 Agilent Technologies, Inc.

13.4.1 Business Overview

13.4.2 Product and Service Offerings

13.4.3 Key Financial Summary

13.4.4 Strategic Growth Plans

13.5 Takara Holdings Inc.

13.5.1 Business Overview

13.5.2 Product and Service Offerings

13.5.3 Key Financial Summary

13.5.4 Strategic Growth Plans

13.6 Promega Corporation

13.6.1 Business Overview

13.6.2 Product and Service Offerings

13.6.3 Strategic Growth Plans

13.7 Bio-Rad Laboratories, Inc.

13.7.1 Business Overview

13.7.2 Product and Service Offerings

13.7.3 Key Financial Summary

13.7.4 Strategic Growth Plans

13.8 Qiagen N.V.

13.8.1 Business Overview

13.8.2 Product and Service Offerings

13.8.3 Key Financial Summary

13.8.4 Strategic Growth Plans

13.9 Lonza Group Ltd.

13.9.1 Business Overview

13.9.2 Product and Service Offerings

13.9.3 Key Financial Summary

13.9.4 Strategic Growth Plans

13.10 New England Biolabs Inc.

13.10.1 Business Overview

13.10.2 Product and Service Offerings

13.10.3 Strategic Growth Plans

Chapter 14. Appendix

14.1 Abbreviations

14.2 Related Reports

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 HEALTHCARE EXPENDITURE AS % OF GDP

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 PRICE OF VARIOUS PRODUCTS OFFERED BY KEY PLAYERS

TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 7 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 8 GLOBAL PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 9 GLOBAL PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 10 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 11 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 12 GLOBAL INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 13 GLOBAL INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 14 GLOBAL YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 15 GLOBAL YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 16 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 17 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 18 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 19 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 20 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 21 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 22 GLOBAL PROTEIN EXPRESSION MARKET, BY REGION, $M (2013 – 2016)

TABLE 23 GLOBAL PROTEIN EXPRESSION MARKET, BY REGION, $M (2017 – 2023)

TABLE 24 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 25 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 26 NORTH AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 27 NORTH AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 28 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 29 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 30 NORTH AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 31 NORTH AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 32 NORTH AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 33 NORTH AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 34 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 35 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 36 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 37 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 38 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 39 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 40 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 41 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 42 EUROPE PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 43 EUROPE PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, $M (2017 – 2023)

TABLE 44 EUROPE PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 45 EUROPE PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 46 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 47 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 48 EUROPE INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 49 EUROPE INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 50 EUROPE YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 51 EUROPE YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 52 EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 53 EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 54 EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 55 EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 56 EUROPE PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 57 EUROPE PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 58 EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 59 EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 60 TOP ASIA-PACIFIC COUNTRIES IN R&D SPENDING

TABLE 61 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 62 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 63 ASIA-PACIFIC PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 64 ASIA-PACIFIC PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 65 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 66 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 67 ASIA-PACIFIC INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 68 ASIA-PACIFIC INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 69 ASIA-PACIFIC YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 70 ASIA-PACIFIC YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 71 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 72 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 73 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 74 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 75 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 76 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 77 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 78 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 79 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 80 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 81 LATIN AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 82 LATIN AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 83 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 84 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 85 LATIN AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 86 LATIN AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 87 LATIN AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 88 LATIN AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 89 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 90 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 91 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 92 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 93 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 94 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 95 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 96 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 97 MEA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2016)

TABLE 98 MEA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2017 – 2023)

TABLE 99 MEA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2016)

TABLE 100 MEA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2017 – 2023)

TABLE 101 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 102 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 103 MEA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 104 MEA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 105 MEA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2016)

TABLE 106 MEA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2017 – 2023)

TABLE 107 MEA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2016)

TABLE 108 MEA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2017 – 2023)

TABLE 109 MEA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 110 MEA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2017 – 2023)

TABLE 111 MEA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2016)

TABLE 112 MEA PROTEIN EXPRESSION MARKET, BY END USER, $M (2017 – 2023)

TABLE 113 MEA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 114 MEA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2017 – 2023)

TABLE 115 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 116 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 117 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 118 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 119 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 120 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 121 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 122 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 123 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 124 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 125 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 126 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 127 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 128 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 129 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 130 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 131 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 132 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 133 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 134 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 135 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 136 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 137 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2013 – 2016)

TABLE 138 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON, BY APPLICATION, $M (2017 – 2023)

TABLE 139 ABNOVA CORPORATION – AT A GLANCE

TABLE 140 GENERAL ELECTRIC COMPANY– AT A GLANCE

TABLE 141 SINO BIOLOGICAL INC. – AT A GLANCE

TABLE 142 BIOVENTIX PLC – AT A GLANCE

TABLE 143 COMPETITIVE ANALYSIS OF KEY PLAYERS

TABLE 144 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE

TABLE 145 THERMOFISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY

TABLE 146 MERCK KGAA – AT A GLANCE

TABLE 147 MERCK KGAA – KEY FINANCIAL SUMMARY

TABLE 148 GENSCRIPT BIOTECH CORPORATION – AT A GLANCE

TABLE 149 GENSCRIPT BIOTECH CORPORATION – KEY FINANCIAL SUMMARY

TABLE 150 AGILENT TECHNOLOGIES, INC. – AT A GLANCE

TABLE 151 AGILENT TECHNOLOGIES, INC. – KEY FINANCIAL SUMMARY

TABLE 152 TAKARA HOLDINGS INC. – AT A GLANCE

TABLE 153 TAKARA HOLDINGS INC. – KEY FINANCIAL SUMMARY

TABLE 154 PROMEGA CORPORATION – AT A GLANCE

TABLE 155 BIO-RAD LABORATORIES, INC. – AT A GLANCE

TABLE 156 BIO-RAD LABORATORIES, INC. – KEY FINANCIAL SUMMARY

TABLE 157 QIAGEN N.V. – AT A GLANCE

TABLE 158 QIAGEN N.V. – KEY FINANCIAL SUMMARY

TABLE 159 LONZA GROUP LTD. – AT A GLANCE

TABLE 160 LONZA GROUP LTD. – KEY FINANCIAL SUMMARY

TABLE 161 NEW ENGLAND BIOLABS INC. – AT A GLANCE

LIST OF FIGURES

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL PROTEIN EXPRESSION MARKET SUMMARY

FIG 9 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 10 PORTER’S FIVE FORCES ANALYSIS

FIG 11 SNAPSHOT OF PROTEIN EXPRESSION MARKET BY SYSTEM (2016)

FIG 12 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 13 GLOBAL PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 14 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 15 GLOBAL INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 16 GLOBAL YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 17 GLOBAL PROTEIN EXPRESSION MARKET SPLIT, BY PRODUCT & SERVICES (2016)

FIG 18 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 19 GLOBAL PROTEIN EXPRESSION MARKET SPLIT, BY APPLICATION (2016)

FIG 20 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 21 GLOBAL PROTEIN EXPRESSION MARKET SPLIT, BY END-USER (2016)

FIG 22 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 23 WORLDWIDE MAJOR MARKETS FOR PROTEIN EXPRESSION

FIG 24 NORTH AMERICA PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 25 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 26 NORTH AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 27 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 28 NORTH AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 29 NORTH AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 30 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 31 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 32 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 33 NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 34 EUROPE PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 35 EUROPE PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 36 EUROPE PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 37 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 38 EUROPE INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 39 EUROPE YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 40 EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 41 EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 42 EUROPE PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 43 EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 44 ASIA- PACIFIC PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 45 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 46 ASIA-PACIFIC PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 47 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 48 ASIA-PACIFIC INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 49 ASIA-PACIFIC YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 50 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 51 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 52 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 53 ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 54 LATIN AMERICA PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 55 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 56 LATIN AMERICA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 57 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 58 LATIN AMERICA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 59 LATIN AMERICA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 60 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 61 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 62 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 63 LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 64 MEA PROTEIN EXPRESSION MARKET SNAPSHOT

FIG 65 MEA PROTEIN EXPRESSION MARKET, BY SYSTEM, $M (2013 – 2023)

FIG 66 MEA PROKARYOTIC EXPRESSION SYSTEM MARKET, BY TYPE, $M (2013 – 2023)

FIG 67 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 68 MEA INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 69 MEA YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, $M (2013 – 2023)

FIG 70 MEA PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICES, $M (2013 – 2023)

FIG 71 MEA PROTEIN EXPRESSION MARKET, BY APPLICATION, $M (2013 – 2023)

FIG 72 MEA PROTEIN EXPRESSION MARKET, BY END USER, $M (2013 – 2023)

FIG 73 MEA PROTEIN EXPRESSION MARKET, BY COUNTRY, $M (2013 – 2023)

FIG 74 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 75 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 76 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 77 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 78 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 79 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT PROTEIN PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 80 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 81 NORTH AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 82 EUROPE MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 83 ASIA-PACIFIC MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 84 LATIN AMERICA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 85 MEA MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTION, BY APPLICATION, $M (2013 – 2023)

FIG 86 GLOBAL MAMMALIAN CELL EXPRESSION SYSTEMS MARKET FOR RECOMBINANT ANTIBODY PRODUCTON – MARKET SHARE OF KEY PLAYERS (2016)

FIG 87 GLOBAL PROTEIN EXPRESSION MARKET SHARE OF KEY PLAYERS (2016)

FIG 88 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 89 REVENUE SPLIT BY SEGMENT (2016)

FIG 90 THERMOFISHER SCIENTIFIC INC. – REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 91 MERCK KGAA – REVENUE SPLIT BY SEGMENT (2016)

FIG 92 MERCK KGAA – REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 93 GENSCRIPT BIOTECH CORPORATION – REVENUE SPLIT BY SEGMENT (2016)

FIG 94 GENSCRIPT BIOTECH CORPORATION – REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 95 AGILENT TECHNOLOGIES, INC. – REVENUE SPLIT BY SEGMENT (2016)

FIG 96 AGILENT TECHNOLOGIES, INC. – REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 97 TAKARA HOLDINGS INC. – REVENUE SPLIT BY SEGMENT (2017)

FIG 98 TAKARA HOLDINGS INC. – REVENUE SPLIT BY GEOGRAPHY (2017)

FIG 99 BIO-RAD LABORATORIES, INC. – REVENUE SPLIT BY SEGMENT (2016)

FIG 100 BIO-RAD LABORATORIES, INC. – REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 101 QIAGEN N.V. – REVENUE SPLIT BY GEOGRAPHY (2016)

FIG 102 LONZA GROUP LTD. – REVENUE SPLIT BY SEGMENT (2016)

FIG 103 LONZA GROUP LTD. – REVENUE SPLIT BY GEOGRAPHY (2016)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ タンパク質発現の世界市場規模・シェア・開発・成長・需要予測(2013~2023年):システム別(原核生物、哺乳類細胞、昆虫細胞、イースト、無細胞、藻類由来)・商品とサービス別(試薬、発現ベクター、適格細胞、サービス、機器)・用途別(治療用、工業用、研究用)・エンドユーザー別(医薬品・バイオテクノロジー企業、学術研究機関、CRO)・地域別(米国、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、中国、インド、日本、ブラジル、メキシコ、南アフリカ)(Protein Expression Market by System (Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, Algal-Based Expression Systems), by Product & Services (Reagents, Expression Vectors, Competent Cells, Services, Instruments), by Application (Therapeutic, Industrial, Research), by End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), by Geography (US, Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa) - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆